✦ LIBER ✦

277 ORAL Interim results of a phase II randomized study of lapatinib (GW572016) as first-line treatment for patients with FISH-amplified advanced or metastatic breast cancer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a phase II study of pemetrexe

✍ Nicholas J. Robert; Paul R. Conkling; Mark A. O’Rourke; Paul R. Kuefler; Kristi 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 234 KB

Phase II Multicenter Study of Docetaxel

✍ Schwartzberg, Lee S.; Badarinath, Suprith; Keaton, Mark R.; Childs, Barrett H. 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 451 KB

A Randomized Phase II Study of Paclitaxe

✍ Adam Brufsky; Karen Hoelzer; Thaddeus Beck; Robert Whorf; Mark Keaton; Padma Nad 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 441 KB

Non-pegylated liposomal doxorubicin comb

✍ S. Del Barco; R. Colomer; L. Calvo; I. Tusquets; E. Adrover; P. Sánchez; J. Rifà 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 220 KB

Results of a Phase II Trial of Cetuximab

✍ Thomas Cartwright; Paul Kuefler; Allen Cohn; William Hyman; Maury Berger; Donald 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 144 KB

A Phase II Multicenter Study of Two Diff

✍ Dittrich, Christian; Solska, Ewa; Manikhas, Alexey; Eniu, Alexandru; Tjulandin, 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 224 KB